Medinol Israel United States of America

About Medinol

At Medinol, we are aggressively changing paradigms in how disease states are diagnosed and treated. Whether designing cutting edge devices for stenting multiple areas of the body, dramatically reducing complications in Structural Heart procedures or providing real time insights into the physiological metrics of the human body through implantable sensors, we boldly reassess current technology and procedures and look years into the future to pioneer new devices to broaden the reach of physicians both physically and geographically. Working with our physician and industry partners, Medinol is creating the future today.

For more information see www.medinol.com or contact Jeff Roach, Chief Commercial Officer at JeffR@medinol.com.

Logo - https://mma.prnewswire.com/media/1894777/Medinol_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/microtech-announces-first-human-case-of-implantable-microsensor-for-heart-failure-302339037.html